BioXcel Therapeutics (BTAI) IPO Opens Flat

Today's IPO for BioXcel Therapeutics (NASDAQ: BTAI) opened for trading at $11.07 after pricing 5.5 million shares at $11.00.

Barclays, UBS Investment Bank and BMO Capital Markets were lead managers of the offering.

You May Also Be Interested In

• CopperTech Metals launches IPO roadshow on NYSE at $16-$18 per share
• 3Knights Dynamics files for IPO on Nasdaq at $4-$5 per share
• ITG launches IPO roadshow, seeks Nasdaq listing at up to $22 per share